Subscribe to Newsletter

Business & Profession

Business & Profession Other

Don’t Disrespect Diamox

| Mark Hillen

Around since the 1950s, it has now been proven to improve visual outcomes in patients with idiopathic intracranial hypertension

Business & Profession Professional Development

Valeant Stalks Allergan

| Mark Hillen

To shave $2.7 billion from costs there will be substantial cuts and job losses

Business & Profession Professional Development

A Touch of Thoughtfulness

| Mark Hillen

Certain patients don't get the treatment that they need. A little understanding and forward planning can solve the problem.

Business & Profession Professional Development

Calling the Plays for Alimera

Sitting Down With Dan Myers, President and CEO of Alimera Sciences, Inc.

Business & Profession Professional Development

Quality Family Time at a Congress

| Nicole Kretz

Grasp the opportunity to take the whole family to conference locations – and gain a new perspective on the places you visit.

Business & Profession Cataract

Selecting for Patient Success

| Alain Saad

Using the best diagnostic tools will help ensure that the right procedures are selected for patients, driving improvements in outcomes for refractive surgery

Business & Profession Other

Stats on stats

| Mark Hillen

An advanced level of statistical knowledge is necessary to critically appraise most ophthalmology literature.

Business & Profession Imaging & Diagnostics

iPhone eye imaging

| Mark Hillen

More money-saving combinations of smartphones and snap-on adapters that enable you to perform eye examinations on-the-go.

Business & Profession Professional Development

The Power of the List

| Richard Gallagher

The Ophthalmologist Power List 2014 is this publication’s catalog of the 100 most influential people in ophthalmology today.

Business & Profession Professional Development

World Travel for a Write up of Your Work

| Mark Hillen

If you’re a retina specialist, you’ll be more likely than not to see patients with diabetic macular edema (DME) on a daily basis. Lasers and anti-VEGF therapy have transformed outcomes within a generation

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: